Knowledge is power...or is it?

Throughout the majority of my treatment, I've not asked many questions about the choices I've been offered. NHS breast cancer treatment is fairly standardised, regardless of where you live or who you see, and every patient is discussed at an MDT to ensure that nothing is missed out when discussing treatment options. I'd heard about a trial, Create-X, whose preliminary results had just been published at a major international conference in December of last year, showing some benefit from further chemotherapy for patients, a bit like me, who hadn't responded to their first chemotherapy.
© 2013 Liz O'Riordan Contact Me